An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer

H. Bonnefoi, K. Zaman, M. Debled, M. Fiche, M. Fournier, M. Nobahar, J-Y Pierga, K. M. Koch, J. Bartlett, A. Zimmer, S. Marreaud, J. Bogaerts, D. Cameron

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences